價格 | ¥248 | ¥579 | ¥828 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:化合物 MI-2 | 英文名稱:Menin-MLL inhibitor MI-2 |
CAS:1271738-62-5 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 97.46% | 產(chǎn)品類別: 抑制劑 |
貨號: T2649 |
名稱 | Menin-MLL inhibitor MI-2 |
描述 | Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM. |
細胞實驗 | The MLL-AF9 and E2A-HLF transduced murine BMC are plated in 12-well plates at the concentration of 5×103 cells/mL with 1 mL methylcellulose medium M3234 containing 20% IMDM medium, 1% penicillin/streptomycin, IL-3 and 0.25% DMSO or compounds. 6 days later colonies are stained with 100 μL iodonitrotetrazolium chloride at final concentration of 1 mg/mL, incubated at 37°C for 30 min and counted. To replate for the 2nd round, colonies are counted at day 6 without staining and cells were washed out by 1×PBS buffer and resuspended in IMDM medium containing 15% FBS, 1% penicillin/streptomycin and IL-3. 5×103 cells are plated in 12-well plates with 1ml methycellulose medium M3234 containing 20% IMDM medium, 1% penicillin/streptomycin, IL-3 and 0.25% DMSO or compounds. 6 days later colonies are stained and counted.(Only for Reference) |
激酶實驗 | High Throughput Screening: FITC-MBM1 at 15 nM and menin at 150 nM in the FP buffer are mixed and incubated for 1h in the dark at room temperature. For point screening, the 0.2 μL of each compound (20 μM final concentration, 1% DMSO) is added to 20 μL of the aliquot of the protein-peptide mixture and incubated on 384-well plates in the dark at room temperature for 1h. In confirmation screening, the serial dilution plates with compounds in DMSO are prepared and used to titrate the menin-FITC-MBM1 complex. Change in fluorescence polarization is monitored at 525 nm after excitations at 495 nm using the PHERAstar microplate reader (BMG) and applied to determine IC50 values with the Origin 7.0 program. |
體內(nèi)活性 | MI-2能有效阻斷含有不同MLL易位的人MLL白血病細胞系的細胞增殖,并誘導細胞凋亡。在HEK293細胞中,MI-2進入蛋白質靶標并有效抑制menin-MLL-AF9相互作用。MI-2通過下調MLL融合蛋白致癌活性必需的靶點基因的表達,有效阻斷MLL融合蛋白介導的白血病轉化。 |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 70 mg/mL (186.4 mM) H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 70 mg/mL (186.4 mM) |
關鍵字 | Menin MLL inhibitor MI 2 | Apoptosis | Inhibitor | Epigenetic Reader Domain | inhibit | Menin-MLL inhibitor MI-2 | MeninMLL inhibitor MI2 |
相關產(chǎn)品 | Metronidazole | 5-Fluorouracil | Curcumin | Stavudine | Tributyrin | Dextran sulfate sodium salt (MW 4500-5500) | Myricetin | Sorafenib | L-Ascorbic acid | Acetylcysteine | Sodium 4-phenylbutyrate | Kaempferol |
相關庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 組蛋白修飾化合物庫 | 細胞凋亡化合物庫 | 抗衰老化合物庫 | NO PAINS 化合物庫 | 表觀遺傳庫 | PPI抑制劑庫 | 細胞重編程化合物庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號
|
2024-11-06 | |
詢價 |
碧云天生物技術有限公司
|
2024-11-05 | ||
詢價 |
VIP2年
|
上海鴻肽生物科技有限公司
|
2024-11-07 | |
¥879.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2024-10-31 | |
詢價 |
VIP2年
|
陜西西化化學工業(yè)有限公司
|
2024-07-24 |